Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chong Sun

Showing results (321-330 of 336) with videos related to

Pageof 34
Sort By:
Nature Communications|May 19, 2025
Dual Ribosome Profiling reveals metabolic limitations of cancer and stromal cells in the tumor microenvironmentDaniela Aviles-Huerta, Rossella Del Pizzo, Alexander Kowar, et al.
Nature|August 17, 2017
Identification of CMTM6 and CMTM4 as PD-L1 protein regulatorsRiccardo Mezzadra, Chong Sun, Lucas T Jae, et al.
Chemical Science|February 16, 2023
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitorFeng Ren, Xiao Ding, Min Zheng, et al.
Annals of Neurology|February 20, 2025
A Multicenter Study of Hereditary Transthyretin Amyloidosis in ChinaXujun Chu, Juan Kang, Jingwen Xu, et al.
Journal of Hepatology|May 17, 2024
Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8<sup>+</sup> T cells in hepatocellular carcinomaChu-Xu Zhu, Kai Yan, Liang Chen, et al.
Cell Reports|June 21, 2016
BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived XenograftsKristel Kemper, Oscar Krijgsman, Xiangjun Kong, et al.
Frontiers in Neurology|October 14, 2022
High-risk screening of late-onset Pompe disease: A different early portrait in ChinaKexin Jiao, Jihong Dong, Sushan Luo, et al.
Nature|March 28, 2014
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanomaChong Sun, Liqin Wang, Sidong Huang, et al.
Nature Communications|February 6, 2026
Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinomaJuanFei Peng, JiaJin Yang, Georgia Antonopoulou, et al.
Neurology. Genetics|June 14, 2019
Loss-of-function mutations in Lysyl-tRNA synthetase cause various leukoencephalopathy phenotypesChong Sun, Jie Song, Yanjun Jiang, et al.
Pageof 34

Showing results (321-330 of 336) with videos related to

Sort By:
Pageof 34
Nature Communications|May 19, 2025
Dual Ribosome Profiling reveals metabolic limitations of cancer and stromal cells in the tumor microenvironmentDaniela Aviles-Huerta, Rossella Del Pizzo, Alexander Kowar, et al.
Nature|August 17, 2017
Identification of CMTM6 and CMTM4 as PD-L1 protein regulatorsRiccardo Mezzadra, Chong Sun, Lucas T Jae, et al.
Chemical Science|February 16, 2023
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitorFeng Ren, Xiao Ding, Min Zheng, et al.
Annals of Neurology|February 20, 2025
A Multicenter Study of Hereditary Transthyretin Amyloidosis in ChinaXujun Chu, Juan Kang, Jingwen Xu, et al.
Journal of Hepatology|May 17, 2024
Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8<sup>+</sup> T cells in hepatocellular carcinomaChu-Xu Zhu, Kai Yan, Liang Chen, et al.
Cell Reports|June 21, 2016
BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived XenograftsKristel Kemper, Oscar Krijgsman, Xiangjun Kong, et al.
Frontiers in Neurology|October 14, 2022
High-risk screening of late-onset Pompe disease: A different early portrait in ChinaKexin Jiao, Jihong Dong, Sushan Luo, et al.
Nature|March 28, 2014
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanomaChong Sun, Liqin Wang, Sidong Huang, et al.
Nature Communications|February 6, 2026
Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinomaJuanFei Peng, JiaJin Yang, Georgia Antonopoulou, et al.
Neurology. Genetics|June 14, 2019
Loss-of-function mutations in Lysyl-tRNA synthetase cause various leukoencephalopathy phenotypesChong Sun, Jie Song, Yanjun Jiang, et al.
Pageof 34